IKT

Inhibikase Therapeutics, Inc. Common Stock

Small CapHealthcareNASDAQ
Moderate47th percentile vs Healthcare stocks

Updated: Oct 30, 2026, 2:17 AM

Open IKT on TradingViewAffiliate link
IKTBELOW 200-DAY

Inhibikase Therapeutics, Inc. Common Stock

$1.67
-13.8% vs 200-day

Position vs 200-day MA

-13.8% below 200-day MA

IKT is 13.8% below its 200-day MA for 14 days. Its standing among Healthcare stocks, the 47th percentile, is unremarkable either way.

Price

$1.67

200-day MA

$1.94

Streak below

14 days

Avg volume (90d)

728.3K

Market cap

$226M

Participation around IKT

Above 200-day MA

IKT's trend and the participation around it are sending mixed signals.

Healthcare

36%

310 of 855 stocks

S&P 500

63%

316 of 498 stocks

This stock is currently below its 200-day average. The comparison shows how much support the move has around it.